Journal: bioRxiv
Article Title: BCAA catabolism drives adipogenesis via an intermediate metabolite and promotes subcutaneous adipose tissue expansion during obesity
doi: 10.1101/2022.08.18.504380
Figure Lengend Snippet: (A) Illustration of partial BCAA catabolic pathway with enzymes, intermediates, and derivatives. (B) Schematic of conditional Bckdk deletion in adipose tissue with Fabp4 ( Ap2 )-Cre. (C) Western blot analysis of BCKDK, p-BCKDE1α, BCKDE1α in the indicated tissues from f/f ( Bckdk f/f ) and AKO ( Ap2-Bckdk -AKO) mice. (D) Metabolomic analysis of BCAA catabolites in the sWAT of Bckdk f/f and Ap2 - Bckdk -AKO mice. (E) Body weight (n=15- 18 per group) of male Bckdk f/f and Ap2-Bckdk - AKO mice on normal chow diet (NCD) for 12 weeks. (F-I) Body composition (n=9-12 per group) (F), organ weight (n=15-16 per group) (G), glucose tolerance test (GTT) (n=15 per group) and the area under the curve (AUC) (H), insulin tolerance test (ITT) (n=8-12 per group) and the area under the curve (AUC) (I) of male Bckdk f/f and Ap2-Bckdk -AKO mice on normal chow diet (NCD) for 6 weeks. (J-M) Oxygen consumption (VO2) (J), carbon dioxide production (VCO2) (K), heat (M), and locomotor activity (L) from 2 weeks HFD-fed male Bckdk f/f and Ap2-Bckdk -AKO mice (n=3- 4 per group). (N) Food intake in Bckdk f/f and Ap2-Bckdk -AKO mice fed NCD (n=12-15 per group) and HFD (n=13 per group). Schematic of conditional Bckdk deletion in adipose tissue with Adipoq -Cre. (P) Western blot analysis of BCKDK, p-BCKDE1α, BCKDE1α in the indicated tissues from f/f ( Bckdk f/f ) and AKO ( Adq-Bckdk -AKO) mice. (Q-S) Body weight (n=12-15 per group) (Q), body composition (n=12-15 per group) (R), and organ weight (n=11-13 per group) (S) of male Bckdk f/f and Adq-Bckdk -AKO mice on high fat diet (HFD) for 12 weeks. Data are represented as mean ± s.e.m. Statistical significance was determined by unpaired two-tailed Student’s t-test or two-way analysis of variance (ANOVA). *p<0.05, ***p<0.001.
Article Snippet: Fatty acid-binding protein 4–Cre recombinase ( Ap2- cre) transgenic mice expressing Cre recombinase under the control of mouse Fabp4 promoter (C57BL/6 background) were from Cyagen Biosciences (Suzhou, China).
Techniques: Western Blot, Activity Assay, Two Tailed Test